Skip to main content
. 2014 Oct 15;124(25):3692–3698. doi: 10.1182/blood-2014-08-595496

Figure 1.

Figure 1

Periprocedural anticoagulation. (A) Bridging strategy suggested in the clinical trial protocol for low-risk patients. (B) Bridging strategy suggested in the clinical trial protocol for intermediate- and high-risk patients. INR, international normalized ratio; LMWH, low-molecular-weight heparin; POC, point of care; UFH, unfractionated heparin.